Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 750 of 1,261
  1. US 9051550

    Cellular seeding and co-culture of a three dimensional fibroblast construct

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  2. US 9051570

    UNA oligomers for therapeutics

    ARCTURUS THERAPEUTICS, INC. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  3. US 9051567

    Methods for increasing efficacy of lipid formulated siRNA

    Tekmira Pharmaceuticals Corporation · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  4. US 9045401

    Methods for treating or ameliorating a melanoma and killing melanoma cells

    The Regents of the University of California · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  5. US 9044518

    Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  6. US 9045416

    WNT protein signalling inhibitors

    The Board of Regents of the University of Texas System · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  7. US 9044514

    Lipid-peptide-polymer conjugates and nanoparticles thereof

    The Regents of the University of California · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  8. US 9045437

    2-aryl-4-quinazolinones and their pharmaceutical compositions

    China Medical University · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  9. US 9044509

    Inhibition of HIV infection through chemoprophylaxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  10. US 9045474

    Compounds and compositions for mitigating tissue damage and lethality

    The Regents of the University of California · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  11. US 9045443

    Nitric oxide donor neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  12. US 9045494

    Orthoester compound

    Nektar Therapeutics · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  13. US 9045752

    NKX3-1 saRNA and KLF4 saRNA and uses thereof

    The Regents of the University of California · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  14. US 9045436

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  15. US 9046520

    Serologic correlates of protection against Bacillis anthracis infection

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  16. US 9045742

    Recombinant Edwardsiella bacterium

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  17. US 9044498

    Lyophilized viral formulations

    ONCOLYTICS BIOTECH INC. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  18. US 9044483

    Cell death inhibition by macrophage migration inhibitory factor and a binding substance thereto

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  19. US 9044482

    Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

    Asana BioSciences, LLC · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  20. US 9044470

    Iminosugars and methods of treating viral diseases

    United Therapeutics Corporation · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  21. US 9044454

    Regulation of microvasculature occlusion

    Northwestern University · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  22. US 9045550

    Peptides and compositions for prevention of cell adhesion and methods of using same

    Tel Hashomer Medical Research, Infrastructure and Services Ltd, the Technology Transfer Company of Chaim · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  23. US 9045526

    Compound and method for modulating opioid receptor activity

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 2, 2015 · Expires May 28, 2035

    granted
  24. US 9044444

    Method for improving skin appearance and reducing hair loss

    China Medical University · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.